EL.En. (ELN) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
24 Mar, 2026Company overview
Global provider of medical, industrial, and conservation laser solutions with over 40 years of proprietary technology expertise.
Listed on Euronext STAR Milan since 2000 and recognized as a tech leader.
Operates in multiple laser application segments, expanding global presence and achieving continuous growth.
Direct presence in 8 countries, with more than 25 subsidiaries and 10 plants.
Workforce exceeds 1,400 employees, with a strong focus on R&D and employee welfare.
Markets and growth drivers
Medical laser market expected to grow at CAGRs between 11% and 17% through 2034, reaching ~$6B in 2024.
Aesthetic laser and energy-based device market also ~$6B in 2024, with CAGRs of 9–12% through 2035.
Industrial laser market valued at $6B in 2024, with CAGRs of 10–11% through 2032.
Key trends include minimally invasive surgeries, aging demographics, and automation in manufacturing.
Strategy and innovation
Continuous investment in R&D, with over €18M annually and more than 130 specialists.
Multi-brand approach and cooperation with research institutions to maintain a broad product range.
Focus on innovative product releases, technical support, and customer training.
Emphasis on sustainability, with 80% of electricity from renewables and 23% self-produced.
Latest events from EL.En.
- Revenue up 4.4% to €591M, net profit down 15.9%, strong cash, cautious 2026 outlook.ELN
Q4 202516 Mar 2026 - Revenue up 5.1% to €285.3M, EBIT and net income down, Chinese unit sold, outlook positive.ELN
Q2 20253 Feb 2026 - Q1 2025 revenue up 8.8%, EBIT up 12%, with strong growth and positive 2025 outlook.ELN
Q1 202522 Jan 2026 - Net income up 7% to €51.6M as medical growth offset industrial decline; 2025 outlook cautious.ELN
Q4 202422 Jan 2026 - Q3 2024 delivered higher profits and margins, driven by medical growth and a major divestment.ELN
Q3 202422 Jan 2026 - Net income rose 5.9% to €27.3M as EBIT is forecast to exceed 2023 despite lower revenue.ELN
H1 202422 Jan 2026 - Majority of the laser cutting division to be sold to YOFC for EUR 55.3M, boosting cash and focus.ELN
Investor Update15 Jan 2026 - Majority stake in Penta Laser Zhejiang sold to YOFC, boosting financial position and growth.ELN
Investor Update26 Dec 2025 - Revenue up 3.9% to €422M, medical leads, financial position strong, 2025 growth confirmed.ELN
Q3 202521 Nov 2025